Who is the CEO of IBRX? | Glauxie AI

Q: Who is the CEO of IBRX?

ImmunityBio, Inc. (IBRX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Richard Gerald Adcock. ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including... Employees: 79,320.

Q: What does IBRX company do?

Learn what IBRX does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling IBRX?

Track recent insider buys and sells for IBRX with transaction details, amounts, and trends.

Q: What sector is IBRX in?

Find IBRX sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of IBRX?

🦉

ImmunityBio, Inc. (IBRX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEORichard Gerald Adcock

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer...

Key Executives

Name	Title
Barry J. Simon	Chief Corporation Affairs Officer & Director
David C. Sachs	Chief Financial Officer
Emily Arison	Senior Vice President of Human Resources
Enrique Diloné	Chief Technology Officer
Hans Georg Klingemann	Chief Science Officer of Cellular
Leonard S. Sender	Chief Medical Officer of Liquid Tumors & Cell Therapy

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

IBRX Profile Financials

What does IBRX company do? Are insiders buying or selling IBRX? What sector is IBRX in?